February 2024
COVID-19 Vaccine Safety Signals: A Global Analysis
Reference: Faksova, K., Walsh, D., Jiang, Y., Griffin, J., Phillips, A., Gentile, A., … & Hviid, A. (2024). COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals. Vaccine. https://doi.org/10.1016/j.vaccine.2024.01.100 Summary: This study evaluates the risk of adverse events following COVID-19 vaccination across
Differential Increases in Excess Mortality in German Federal States During the COVID-19 Pandemic
Reference: Kuhbandner, C., & Reitzner, M. (2024). Differential increases in excess mortality in the German federal states during the COVID-19 pandemic. Preprint. https://doi.org/10.13140/RG.2.2.13098.18880 Summary: This study examines excess mortality across Germany’s sixteen federal states during the COVID-19 pandemic from April 2020 to March 2023. It utilises statistical methods to assess the observed versus expected deaths,